Figure 7.

Forest plot showing the risk ratio for induction of remission in patients treated with or without rituximab at 6 months and at study end. There is no significant difference between the groups.

Walters et al. BMC Nephrology 2010 11:12   doi:10.1186/1471-2369-11-12
Download authors' original image